OncoSil Medical Limited (ASX:OSL)
1.500
+0.010 (0.67%)
Oct 28, 2025, 4:10 PM AEST
OncoSil Medical Market Cap
OncoSil Medical has a market cap or net worth of 28.24 million as of October 28, 2025. Its market cap has decreased by -46.70% in one year.
Market Cap
28.24M
Enterprise Value
23.20M
Revenue
1.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.50
Market Cap Chart
Since August 15, 2005, OncoSil Medical's market cap has increased from 7.29M to 28.24M, an increase of 287.08%. That is a compound annual growth rate of 6.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 28.24M | 2.39% |
| Dec 31, 2024 | 27.58M | 55.21% |
| Dec 28, 2023 | 17.77M | -60.28% |
| Dec 30, 2022 | 44.74M | 25.48% |
| Dec 31, 2021 | 35.65M | -63.58% |
| Dec 31, 2020 | 97.90M | -8.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 102.70B |
| Pro Medicus | 29.45B |
| Cochlear | 18.98B |
| Sonic Healthcare | 10.75B |
| Ramsay Health Care | 7.34B |
| Telix Pharmaceuticals | 5.59B |
| Ansell | 4.84B |
| Mesoblast | 3.30B |